In order to achieve our translational goals, we collaborate closely with the clinical research platform. By collaborating with the clinic, we are able to share access to a limited pool of patient samples, and translating our experimental findings to human biology via so called “proof of concept” studies performed using ex vivo cultures of human tissue biopsies.
Our main facilities are Steno Diabetes Center Aarhus (SDCA) is a leading translational research environment due to its close integration of clinical care and research. SDCA fosters collaboration between clinicians, scientists, and patients, allowing real-world insights to directly inform cutting-edge research. This synergy accelerates the translation of discoveries into effective treatments and innovations for diabetes care. With state-of-the-art facilities and a strong focus on interdisciplinary approaches, SDCA ensures that scientific advancements rapidly benefit patients. Furthermore, its commitment to education and collaboration with international research networks makes it a hub for knowledge sharing and a model of excellence in diabetes translational research. In addition, we have a clinical site at the Department of Clinical Immunology and transfusion Medicine at Sahlgrenska Hospital, and we also work closely with Viborg University Hospital.
Our main facilities are Steno Diabetes Center Aarhus (SDCA) is a leading translational research environment due to its close integration of clinical care and research. SDCA fosters collaboration between clinicians, scientists, and patients, allowing real-world insights to directly inform cutting-edge research. This synergy accelerates the translation of discoveries into effective treatments and innovations for diabetes care. With state-of-the-art facilities and a strong focus on interdisciplinary approaches, SDCA ensures that scientific advancements rapidly benefit patients. Furthermore, its commitment to education and collaboration with international research networks makes it a hub for knowledge sharing and a model of excellence in diabetes translational research. In addition, we have a clinical site at the Department of Clinical Immunology and transfusion Medicine at Sahlgrenska Hospital, and we also work closely with Viborg University Hospital.
"Proof-of-concept” studies are performed using ex vivo cultures of human tissue biopsies.
